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DNA methylation and histone modification exert
epigenetic control over gene expression. CHGmeth-
ylation by CHROMOMETHYLASE3 (CMT3) depends
on histone H3K9 dimethylation (H3K9me2), but the
mechanism underlying this relationship is poorly
understood. Here, we report multiple lines of evi-
dence that CMT3 interacts with H3K9me2-contain-
ing nucleosomes. CMT3 genome locations nearly
perfectly correlated with H3K9me2, and CMT3 stably
associated with H3K9me2-containing nucleosomes.
Crystal structures of maize CMT3 homolog ZMET2,
in complex with H3K9me2 peptides, showed that
ZMET2 binds H3K9me2 via both bromo adjacent
homology (BAH) and chromo domains. The struc-
tures reveal an aromatic cage within both BAH
and chromo domains as interaction interfaces that
capture H3K9me2. Mutations that abolish either
interaction disrupt CMT3 binding to nucleosomes
and show a complete loss of CMT3 activity in vivo.
Our study establishes dual recognition of H3K9me2
marks by BAH and chromo domains and reveals
a distinct mechanism of interplay between DNA
methylation and histone modification.
INTRODUCTION
DNA methylation and histone modification are two major epige-
netic marks regulating gene expression and chromatin state.
Eukaryotic DNA is wrapped around a histone octamer that
consists of two of each of the four core histones H2A, H2B,
H3, and H4 and forms the basic structural unit of chromatin:
the nucleosome (Luger et al., 1997). The formation of hetero-chromatin involves the recruitment of silencing complexes con-
taining histone-binding and -modifying proteins and the genera-
tion of specific silent epigenetic modification patterns. In animals
and Schizosaccharomyces pombe, methylation of histone H3 at
lysine 9 (H3K9) is associated with silenced heterochromatic
regions and is bound by the silencing protein Heterochromatin-
associated protein 1 (Jenuwein and Allis, 2001). In plants, dime-
thylation of H3K9 (H3K9me2) is required for the silencing of
transposable elements (TEs) and other repetitive DNA, which
are enriched in heterochromatic regions (Bernatavichute et al.,
2008; Jackson et al., 2002, 2004; Malagnac et al., 2002).
DNA methylation in mammals is mainly found at CG sites and
is initially catalyzed by the de novo methyltransferase DNMT3A/
B and subsequently maintained by DNMT1. In contrast, DNA
methylation in plants exists in three sequence contexts: CG,
CHG (where H is either C, T, or A), and CHH (or asymmetric)
(Cokus et al., 2008). While METHYLTRANSFERASE1 (MET1,
an ortholog of mammalian DNMT1) maintains CG methylation
and DOMAINS REARRANGED METHYLTRANSFERASE 2
(DRM2, an ortholog of mammalian DNMT3) primarily maintains
CHH methylation, CHROMOMETHYLASE3 (CMT3) is a plant-
specific methyltransferase responsible for CHG methylation in
Arabidopsis thaliana (Bartee and Bender, 2001; Law and
Jacobsen, 2010; Lindroth et al., 2001). The CMT3 ortholog in
maize, the Zea mays methyltransferase2 (ZMET2), was also
shown to be required for CHG DNA methylation (Papa et al.,
2001).
DNA methylation and histone modifications have been corre-
lated in multiple organisms. In mammals, de novo methyltrans-
ferase DNMT3A and its cofactor DNMT3L form a complex that
specifically recognizes unmodified H3K4 through the ADD
domains (Ooi et al., 2007; Otani et al., 2009). UHRF1 is a key
factor connecting DNMT1 and H3K9 methylation by binding
methylated DNA through the SRA domain (Bostick et al.,
2007), H3K9me3 through a tandem Tudor (Nady et al., 2011;
Xie et al., 2012) and unmodified H3R2 through an atypical PHDCell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc. 167
finger domain (Rajakumara et al., 2011b; Xie et al., 2012). In
plants, H3K9me2 is mainly associated with heterochromatic
TEs and correlated with CHG methylation (Bernatavichute
et al., 2008). The SRA domain of the H3K9 methyltransferase
KRYPTONITE (KYP; also called SUVH4) directly binds tomethyl-
ated CHG-containing oligonucleotides (Johnson et al., 2007).
Based on these results, a self-reinforcing loop was proposed,
in which CMT3 is recruited by H3K9me2 deposited by KYP
and its close homolog (SUVH5 and SUVH6), to methylate
CHG. In turn, methylated CHG DNA recruits KYP to maintain
methylation of H3K9 (Johnson et al., 2007; Law and Jacobsen,
2010).
To investigate the molecular mechanism underlying the rela-
tionship between CHG methylation and histone H3K9 methyla-
tion, we carried out structural and functional studies on CMT3
and ZMET2. We found that CMT3 is stably associated with
heterochromatic nucleosomes. Consistent with its role in DNA
methylation maintenance, we found that CMT3 was predomi-
nantly expressed in actively replicating cells and was specifically
associated with replication dependent histone H3 variants.
Genome-wide mapping of CMT3 binding sites demonstrated
that CMT3 is nearly perfectly correlated with H3K9me2 in vivo.
Chromatin association of CMT3 is dependent on specific binding
of H3K9me2 via the bromo adjacent homology (BAH) and
chromo domains as shown by our crystal structures of ZMET2
in complex with H3K9me2 peptides. The structures identify an
aromatic cage within both the BAH and the chromo domains
as interaction interfaces that capture H3K9me2. Mutations that
abolish either interaction cause a failure of CMT3 binding to
nucleosomes, and a complete loss of CMT3 activity in vivo.
Together, these results suggest that CMT3 associates with
H3K9me2-containing nucleosomes through dual binding of its
BAH and chromo domains to H3K9me2 in order to target DNA
methylation.
RESULTS
CMT3 Is Associated with H3K9me2-Containing
Nucleosomes
To identify CMT3-interacting proteins, we generated epitope-
tagged CMT3 lines. As shown in Figure 1A, both pCMT3:BLRP-
3xFLAG-CMT3 and pCMT3:BLRP-9xMYC-CMT3, designated
as FLAG-CMT3 and MYC-CMT3, respectively, complemented
the cmt3 mutation and restored DNA methylation at the 5S
rDNA locus, demonstrating that epitope-tagged CMT3 was
functional in vivo. We found a major band at the size of CMT3
and a series of smaller bands that corresponded to the size of
individual histone proteins (Figure 1B). As shown in Table 1
from mass spectrometry (MS) analysis, peptides corresponding
to CMT3 were the most abundant proteins with 63.4% coverage
of the CMT3 protein. We also identified all four core histones: H3,
H4, H2A, and H2B at roughly equivalent levels and observed
several linker H1 histones, as well as Ku70/80 proteins (Table 1;
Figure S1 available online) that were likely bound to the sheared
DNA ends, suggesting that CMT3 interacts with bona fide
nucleosomes.
To test whether CMT3 specifically interacts with histone H3,
we treated plant extracts with benzonase, a nonspecific168 Cell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc.nuclease, to remove DNA prior to affinity purification. We found
that benzonase treatment eliminated the low molecular weight
histone bands (Figure 1C). MS analysis further confirmed that
H2A, H2B, H3, H4, and Ku70/80 were no longer detectable
(Table S2). This suggests the integrity of nucleosomes is critical
for CMT3 binding, and that CMT3 does not interact with H3
strongly on its own in vivo.
To investigate whether CMT3 is associated with H3K9me2-
containing nucleosomes, we tested for the presence of
H3K9me2 marks in histones copurified with CMT3 and found
that H3K9me2, but not H3K4me2, was precipitated with CMT3
(Figure 1D). This indicates that CMT3 preferentially binds to
H3K9m2-containing nucleosomes.
CMT3 Is Enriched in Heterochromatic Regions and
Highly Correlated with H3K9me2
To further explore the in vivo binding pattern of CMT3, we per-
formed chromatin immunoprecipitation coupled with sequenc-
ing (ChIP-seq) (Figure 1E). We found that CMT3 is highly
enriched in Arabidopsis pericentromeric regions and is nearly
perfectly colocalized with H3K9me2 (Figure 2A). CMT3 is also
enriched in heterochromatic patches in the euchromatic arms,
where high levels of H3K9me2 were also observed (Figure 2B).
CMT3 tends to bind large uninterrupted blocks in pericentro-
meric regions, while in chromosome arms CMT3 forms smaller
and isolated patches (Figure 2C). These results are consistent
with the general trend of H3K9me2 distribution in these regions
(Bernatavichute et al., 2008). Furthermore, CMT3 was not en-
riched over protein coding genes (Figure 2D), consistent with
previous data showing that the majority of genes are devoid of
CHG methylation and H3K9me2 (Cokus et al., 2008). We also
found a strong enrichment of CMT3 over TEs (Figure 2E). To
complement the ChIP-seq data, we examined the transcriptome
profile of cmt3 mutants by whole genome RNA sequencing
(RNA-seq) analysis. As expected, CMT3 was strongly enriched
over the TEs that were upregulated in cmt3 mutants (Figure 2F),
as were H3K9me2 and CHG methylation (Figures 2G and S1A).
To determine the specificity of CMT3 binding to histone marks
in vitro, we screened full-length CMT3 on a peptide array and
found that CMT3 can bind to mono-, di-, and trimethylated
H3K9 peptides, with preference for di- and trimethylated H3K9
peptides (Figure 2H). In plants, H3K9me2 is highly enriched in
heterochromatin and TEs, and functionally associated with
DNA methylation. In contrast, H3K9me3 is found in low abun-
dance in euchromatic regions in plants and its functional role is
still unknown (Roudier et al., 2011). In addition, CMT3 binding
was blocked by phosphorylation of Ser10 and Thr11 on H3
(Figure 2H).
Collectively, the nearly perfect correlation between CMT3
binding sites with H3K9me2 sites in the genome and the direct
interaction of CMT3 and H3K9me2-containing nucleosomes
and histone tail peptides support the role of H3K9me2 in recruit-
ing CMT3 to chromatin in vivo.
CMT3 Is Primarily a CHG Methyltransferase In Vitro and
Is Predominantly Expressed in Actively Replicating Cells
To determine whether CMT3 is active in vitro, recombinant
CMT3 protein was assayed on a set of oligonucleotide
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Figure 1. CMT3 Is Associated with Histones In Vivo
(A) Complementation analysis by Southern blot at 5S rDNA locus. Genomic DNAwas digested with themethylation-sensitiveMspI restriction enzyme. The (unMe)
DNA fragment was the unmethylated DNA and (Me) DNA fragments were generated when MspI digestion was blocked by DNA methylation. The two lanes
indicated by a horizontal line are from two independent transgenetic plant lines. Wild-type Columbia ecotype (WT) is a control.
(B) Silver stained SDS-PAGE gel showed the presence of histone proteins in CMT3, but not in CMT3chr3 and CMT3bah3.
(C) Histone proteins were absent from protein complexes after benzonase treatment.
(D) CMT3 specifically pulls down H3K9me2.
(E) Outline of CMT3 affinity purification procedure for mass spectrometry and ChIP-seq.
See also Tables S1 and S2.substrates with cytosines either unmethylated or premethylated
at CG, CHG, or CHH sites (Table S3). As shown in Figure 3A,
CMT3 methylated oligonucleotides that were either unmethy-
lated or hemimethylated at CHG sites, while it lost the majority
of its activity when CHG sites were blocked by premethylation
on both strands. We also performed bisulfite sequencing of an
in vitro methylated plasmid DNA and observed 10% CHG meth-
ylation, 1.4%CHHmethylation, and 0%CGmethylation, with an
error rate of 0.4% (Figure 3B). These results provide direct
evidence that CMT3 is indeed amethyltransferase that preferen-
tially methylates CHG sites.
During DNA replication, fully methylated DNA becomes hemi-
methylated, and can become completely unmethylated in the
following round of replication if methylation is not properly main-
tained. If CMT3 efficiently converts hemimethylated DNA to fullymethylated DNA in vivo, then one should observe a large number
of fully methylated CHG sites and a smaller number of hemime-
thylated sites in the genome. To test this, we utilized Hairpin
Bisulfite Sequencing (Laird et al., 2004) at the Ta3 transposon.
We found that the number of observed fully methylated dyads
exceeded the number of expected fully methylated dyads occur-
ring at random by a small but significant number (Figure 3C).
These results suggest that CMT3 has a significant in vivo prefer-
ence for conversion of hemimethylated sites to fully methylated
sites and in this way acts as a maintenance methyltransferase.
Our MS results showed that the replication-dependent H3
(H3.1), known to be expressed in S phase (Okada et al., 2005),
but not the replication-independent H3 (H3.3), copurified with
CMT3 (Table S4). In addition, an analysis of publicly available
microarray data shows that CMT3 expression is highlyCell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc. 169
Table 1. Summary of Proteins Associated with CMT3 Identified by Mass Spectrometric Analyses
Protein AGI Code Spectra Unique Peptides % Coverage NSAFe5 % CMT3
CMT3 At1g69770 756 131 63.4 7,240 100
H1 At1g06760 19 11 31.8 557 7.7
H1 At3g18035 29 17 22.3 485 6.7
H1/H5 At1g48620 28 12 17.3 470 6.5
H1.2 At2g30620 46 16 47.3 1,353 18.7
HTA13 At3g20670 50 7 21.2 3,043 42.0
HTA6 At5g59870 18 4 17.3 964 13.3
HTA9 At1g52740 15 4 30.6 899 12.4
HTA7 At5g27670 15 3 8.0 803 11.1
HTA12 At5g02560 5 2 7.8 262 3.6
HTA8 At2g38810 15 4 32.4 251 3.5
H2Ba At5g02570 59 13 32.6 3,675 50.8
At3g09480
H2B At2g37470 62 15 46.4 3,610 49.9
H2B At3g53650 32 8 30.4 1,863 25.7
H2Ba At5g59910 79.6 16.6 42.2 4,327 59.8
At1g07790
At5g22880
At3g45980
At3g46030
H3a At5g10400 63 21 52.9 3,674 50.7
At1g09200
At5g10390
At5g65360
At3g27360
HTR12 At1g01370 2 2 25.3 90.3 1.2
H4a At1g07820 26 13 62.1 2,028 28.0
At3g3730
At2g28740
At5g59970
At3g46320
At3g45930
At5g59690
At1g07660
Ku80 At1g48050 24 19 33.8 284 3.9
Ku70 At1g16970 10 8 16.7 129 1.8
The percentage of CMT3 (% CMT3) column indicates the approximate stoichiometry of each copurifying protein as a function of the normalized spec-
tral abundance factor (NSAF) (Law et al., 2010). See also Table S1.
aUnique peptides map to the group of these genes.correlated with proteins that are actively expressed during DNA
replication (Figure S1B). We also directly examined the localiza-
tion of CMT3 in replicating root cells. To detect cells undergoing
replication, 5-ethynul-20-deoxyuridine (EdU), a thymidine analog
that is incorporated into dividing cells during S phase (Chehre-
hasa et al., 2009), was used to label newly synthesized DNA.
We observed high accumulations of CMT3 in actively replicating
cells as labeled by EdU (Figure 3D). CMT3 also accumulated in
cells not undergoing DNA replication, but at a much lower level
than that in replicating cells (Figure 3D).170 Cell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc.Together, these results suggest that CMT3 is an active
DNA methyltransferase that is predominately expressed in the
S phase of actively replicating cells and binds to nucleosomes
that contain replication dependent histone variants.
Structure of SAH-Bound ZMET2
The CMT3 homolog in Zea mays, ZMET2 (Figures 4A and S2A),
has a similar binding specificity to methylated H3K9 on the
peptide array (Figure 2H) and similar methyltransferase activity
on CHG sites (Figure S2B). Although we were unable to
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Figure 2. CMT3 Is Enriched in Heterochromatic Regions and Highly Correlated with H3K9me2
(A) Distribution of CMT3 (black) and H3K9me2 (red) along the five Arabidopsis chromosomes.
(B) CMT3 ChIP-seq signal is enriched in heterochromatic patches in the arms.
(C) Genome browser views of pericentromeric and euchromatic regions. mCG, CG methylation; mCHG, CHG methylation; mCHH, CHH methylation; TE,
transposable element; PCG, protein coding gene.
(D and E) CMT3 ChIP-seq signal is not enriched in the protein coding gene regions (D), but is enriched in TEs (E).
(F and G) CMT3 (F) and H3K9me2 (G) are enriched in TEs that are upregulated in cmt3 null mutants.
(H) CMT3 and ZMET2 specifically bind to mono-, di-, and trimethylation of H3K9. Blue, red, and yellow circles in right panel represent the locations of mono-, di-,
and trimethylation at lysine 9-containing peptides on the array, respectively.
See also Figure S1A.
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Figure 3. CMT3 Is Primarily a CHG Methyltransferase and Predominantly Expressed in Actively Replicating Cells
(A) CMT3 has activity on both unmethylated and hemimethylated DNA oligos, but not fully methylated DNA oligos containing methylations at all cytosines. Error
bars represent the SD of three replicates.
(B) Bisulfite sequencing of in vitro methylated plasmid DNA.
(C) Hemimethylated dyads at the Ta3 locus were significantly lower than expected (chi-square value: 32.84). Probability of obtaining the observed distribution by
random chance is less than 0.1%.
(D) Accumulation of CMT3 in cells with active replication. DAPI staining shows the localization of nuclei (blue). Actively replicating cells were labeled by 5-ethynul-
20-deoxyuridine (EdU, Red) and CMT3 was immunostained by MYC antibody (green).
See also Figure S1B and Tables S3 and S4.crystallize CMT3, we were successful in obtaining diffraction
quality crystals for an N-terminal truncated version of ZMET2
(residues 130–912, Figure 4A), containing all the functional
domains, along with the cofactor SAH and the structure was
refined to 3.2 A˚ resolution (Figure 4B; Table S5). The BAH and
chromo domains project outward in opposite directions relative
to the methyltransferase domain (Figure 4B). The overall
topology is that of an equilateral triangle with each edge of about
85–100 A˚ in length. The BAH domain, the target recognition sub-
domain (TRD) of the methyltransferase domain, and the chromo-
domain are positioned at the three vertices, while the catalytic
subdomain of the methyltransferase domain is positioned within
the interior of the triangular architecture (Figure 4B).172 Cell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc.The BAH domain of ZMET2, composed of a twisted b barrel
with some extended segments, resembles BAH1 domain of
mouse DNMT1. Although they only share a sequence identity
of 26%, the superposition of the BAH domains of ZMET2 and
mouse DNMT1 yields an rmsd of 1.9 A˚ for 121 aligned Ca atoms,
showing a similar folded topology (Figure S2C). The position of
the BAH domain relative to its methyltransferase domain in
ZMET2 is also similar to that of BAH1 domain of DNMT1 relative
to its methyltransferase domain, indicating a plausible similar
function for the BAH domains of these two proteins.
The methyltransferase domain of ZMET2 adopts a typical
class-I methyltransferase fold composed of catalytic and TRD
subdomains. The catalytic subdomain of ZMET2 resembles the
AB
C D
Figure 4. Binding to Methylated Peptides
and the Structure of ZMET2 in the Free State
(A) Color-coded domain architecture of full-
length CMT3, ZMET2, and the ZMET2(130–912)
construct used to grow crystals.
(B) Ribbon representation of the structure of
ZMET2 with bound SAH. The BAH, methyl-
transferase, and chromo domains are colored in
orange, green, and blue, respectively, with the
bound SAH molecule shown in a space filling
representation. Some disordered regions were not
built in the final model and are shown as dashed
lines.
(C and D) ITC binding curves for complex forma-
tion between ZMET2 chromo (C) and BAH (D)
domains and H3K9me2, H3K27me2, H4K20me2,
and unmodified H3 peptides. Kd values are listed
as an insert.
See also Figure S2 and Table S5.corresponding folds adopted by DNMT1 (Song et al., 2011) and
DNMT3A (Jia et al., 2007), with a central seven-stranded b sheet
flanked by two layers of a-helical segments on either side.
Similar to its topology in DNMT1, the central seven-stranded
b sheet of the catalytic subdomain of ZMET2 forms a continuous
nine-stranded b sheet by pairing with two additional b strands
from the BAH domain (Figure 4B), thereby probably stabilizing
the relative positioning of the BAH and methyltransferase
domains of ZMET2. A SAH molecule is positioned in the active
site of the catalytic subdomain. The TRD subdomain of
ZMET2, consisting of 206 residues (612–818), has a well-defined
continuous peptide backbone, but poor density for some side
chains, which were consequently modeled as polyalanine.
Although the primary sequence implies that the chromodo-
main of ZMET2 is embedded within the methyltransferaseCell 151, 167–180, Sedomain, it buds out from one side of
the methyltransferase domain in the
structure (Figure 4B), therefore forming
an independent structural module that
does not affect the topology of the
methyltransferase domain. The chromo-
domain uses several hydrophobic resi-
dues to form a continuously hydrophobic
surface that interacts with its hydro-
phobic counterpart on the surface of the
methyltransferase domain (Figure S2D).
This interaction positions the chromodo-
main on one side of themethyltransferase
domain, indicative of a relatively rigid
alignment between chromo and methyl-
transferase domains. The ZMET2 chro-
modomain adopts a typical chromodo-
main topology, which resembles that
of methylated H3K9-binding chromodo-
mains, such as the MPP8 chromodomain
(rmsd of 1.1 A˚ for 57 aligned Ca atoms)
and the HP1 chromodomain (rmsd of1.2 A˚ for 52 aligned Ca atoms) (Chang et al., 2011; Jacobs and
Khorasanizadeh, 2002).
Structural Basis for H3(1–15)K9me2 Peptide
Recognition by ZMET2 Chromodomain
To investigate the molecular basis for H3K9me2 recognition by
ZMET2, we first performed isothermal calorimetric (ITC) binding
studies and established that the chromodomain of ZMET2-
bound H3K9me2 and H3K9me3 with a Kd of 2.3 (Figure 4C)
and 2.0 mM (data not shown), respectively, whereas it bound
only weakly to unmodified H3, as well as H3K27me2 and
H4K20me2 peptides (Figure 4C). Unexpectedly, ITC binding
studies also established that the BAH domain of ZMET2 also
exhibits strong binding affinity for H3K9me2 and H3K9me3
with a Kd of 0.5 mM (Figure 4D) and 0.7 mM (data not shown)ptember 28, 2012 ª2012 Elsevier Inc. 173
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Figure 5. Structure of Chromo and BAH Domains of ZMET2 with Bound H3K9me2 Peptide
(A and D) Ribbon representation of the structure of ZMET2(130–912) complexes with H3(1–15)K9me2 (A) and H3(1–32)K9me2 peptide (D). The color coding is the
same as in Figure 4B. The bound peptide and SAH are shown in a space-filling representation, with the orientation of the bound peptide shown by an arrow.
(B and E) Intermolecular interactions between the chromodomain of ZMET2 and H3(1–15)K9me2 peptide (B) and between the BAH domain of ZMET2 and
H3(1–32)K9me2 peptide (E). The dimethylammonium group of K9 is accommodated within an aromatic cage. Intermolecular hydrogen bonds are designated by
dashed red lines.
(C and F) A schematic representation of the intermolecular interactions between the chromodomain of ZMET2 and the bound H3(1–15)K9me2 peptide (C) and
between the BAH domain of ZMET2 and the bound H3(1–32)K9me2 peptide (F).
See also Figures S3, S4, and S5 and Table S5.and weak binding for unmodified H3 and H4K20me2 peptides,
and exhibited very reduced affinity to H3K27me2 peptide (Kd
of 17 mM) (Figure 4D).
We then crystallized ZMET2 in complex with H3(1–15)K9me2
peptide in the presence of SAH at 3.2 A˚ resolution (Figure 5A;
Table S5). There are two molecules of ZMET2 and one molecule
of H3K9me2 peptide bound to one of the two chromodomains in
the asymmetric unit (Figures S3A and S3B). The overall structure
of ZMET2 bound to the H3(1–15)K9me2 peptide resembles the174 Cell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc.structure of ZMET2 in the free state (Figure 4B and Figure 5A).
The H3(1–15)K9me2 peptide binds to the chromodomain in
a classic chromodomain-binding mode (Figure 5A) and the
bound peptide can be traced from Gln5 to Thr11 (Figure S3C).
The peptide is clamped within the chromodomain in a
b strand-like conformation. The K9me2 side chain inserts into an
aromatic cage, which is formed by Phe441, Trp466, and Tyr469,
and stabilized by extensive hydrophobic interactions (Figures 5B
and 5C). These three aromatic cage-forming residues are
conserved with CMT3 and the classic H3K9me3-recognizing
HP1 chromodomain (Figures S3D and S3E), suggesting a similar
methylated-lysine binding properties within this family. The resi-
dues adjacent to K9me2 are also involved in sequence specific
recognition, with Arg8 of the histone peptide forming two inter-
molecular hydrogen bonds, as well as electrostatic interactions
with the side chain of Glu440 of the protein. The main chain of
Arg8 also forms two hydrogen bonds with Asn481 and the back-
bone and side chain of Ser10 forms hydrogen bonds with the
side chain of Glu477 of the protein (Figures 5B and 5C), consis-
tent with our observation that Ser10 phosphorylation inhibits its
binding to CMT3 (Figure 2H). In addition, the backbone of
Gln5, Thr6, and Ala7 form intermolecular hydrogen bonds with
the protein (Figures 5B and 5C).
Structural Basis for H3(1–32)K9me2 Peptide
Recognition by ZMET2 BAH Domain
We further determined the structure of another crystal form of
ZMET2 in complex with a longer H3(1–32)K9me2 peptide at
2.7 A˚ resolution that revealed a distinct binding mode of the
H3K9me2 peptide to the BAH domain of ZMET2 (Figure 5D;
Table S5). Due to the different packing arrangement in this
crystal, the peptide-binding site within the chromodomain was
blocked by the other molecule in the asymmetric unit (Figures
S4A and S4B), and hence no peptide was found to bind to the
chromodomain.
The structure contains two molecules of ZMET2, with
H3K9me2 peptides bound to each of the BAH domains, in the
asymmetric unit (Figure S4A). The packing results in the chromo-
domain of one molecule being clamped by the TRD subdomain
and the catalytic loop of the second molecule (Figure S4A).
These intermolecular interactions stabilize the conformation of
the TRD subdomain and catalytic loop, and hence it became
possible to trace all the side chains of the TRD subdomain and
the catalytic loop, while they could not be fully built in the
H3(1–15)K9me2 complex. The electron density was traceable
from Gln5 to Thr11 for the H3(1–32)K9me2 peptide bound to
the BAH domain in one complex (Figure S4C), while a somewhat
shorter segment was traceable in the other complex. The side
chain of K9me2 inserts into an aromatic cage formed by
Tyr203, Trp224, and Phe226 of the BAH domain (Figure 5E).
These aromatic residues are also conserved in CMT3, sugges-
tive of a conserved function (Figure S4D). By contrast, flanking
peptide residues form fewer interactions with the protein in the
H3(1–32)K9me2 complex (Figures 5E and 5F) than they do in
the H3(1–15)K9me2 complex (Figures 5B and 5C). The methyl
group Ala7 is recognized within a small hydrophobic pocket
formed by Val194, Tyr203, and Trp224 in the H3(1–32)K9me2
complex (Figures 5E and 5F). In addition, the backbone amide
protons of Ala7, Arg8, and Ser10 form intermolecular hydrogen
bonds with the BAH domain (Figures 5E and 5F). These studies
establish the BAH domain of ZMET2 also as a reader of
H3K9me2, with its aromatic cage playing a key role in methyl-
lysine recognition.
ZMET2 has a relatively large TRD subdomain of around 206
residues with a unique fold (Figure S5A). In regions proximal to
the catalytic center (middle and bottom segments of Figure S5A),
the ZMET2 TRD subdomain adopts a helixes and loops similar tothose observed for DNMT1 (Song et al., 2011), indicating the
likelihood of a similar DNA substrate recognition mechanism.
However, in regions further from the catalytic center (top
segment of Figure S5A), the TRD subdomains of DNMT1 and
ZMET2 show different structural features. For DNMT1, regions
of the TRD subdomain further from the catalytic center are
enriched with loops and a coordinated zinc ion. In addition,
a long loop extending outward from BAH2 domain of DNMT1
(Figure S5A) interacts at its tip with the TRD subdomain, sugges-
tive of a plausible regulatory role. By contrast, ZMET2 has
neither a second BAH domain, nor a bound zinc ion. The space
occupied by the BAH2 loop-interacting region on the TRD sub-
domain in DNMT1 is partially occupied by a two-stranded anti-
parallel b sheet in ZMET2 (Figure S5A). These observations imply
that though ZMET2 might have a potentially similar DNA recog-
nition mode as DNMT1, its regulatory mechanism could be
different.
The catalytic loop region is disordered for structures of ZMET2
in the free state and in the complex with H3(1–15)K9me2
peptide, but is well defined in the complex with H3(1–32)
K9me2 peptide.We observe that the catalytic loop (in red, stereo
view in Figure S5B) and catalytic cysteine (labeled C in red, Fig-
ure S5B) of ZMET2 in its peptide-bound form is directed outward
from the catalytic center, similar to that of DNMT1 bound to DNA
in its autoinhibitory conformation (labeled C in blue, Figure S5B)
(Song et al., 2011). By contrast, the catalytic loop (in green) and
catalytic cysteine (labeled C in green, Figure S5B) are directed
inward toward the catalytic center in the active form of M.HhaI
bound to DNA (Klimasauskas et al., 1994) and the active form
of DNMT1 bound to hemimethylated DNA (Song et al., 2012).
These results are consistent with ZMET2 being in an inactive
conformation in the peptide-bound state in the absence of
bound DNA.
Both BAH and Chromo Domains Are Important for CMT3
Function In Vivo
To study the biological significance of CMT3 andH3K9me2 inter-
action, wemutated the three aromatic residues lining themethyl-
lysine-binding aromatic cages in the chromo (Phe382, Trp409,
and Tyr412) and the BAH (Phe127, Trp148, and Tyr150)
domains to generate triple point mutants named CMT3chr3
and CMT3bah3, respectively. We also generated a catalyti-
cally inactive C460A mutant (CMT3cat). Notably, CMT3cat,
CMT3chr3 and CMT3bah3 failed to restore DNA methylation at
the 5S rDNA (Figure 6A) and at the Ta3 (Figure 6B), even though
themutated proteinswere expressed at a similar level (Figure 6C)
and CMT3chr3 had similar catalytic activity as wild-type CMT3
(Figure 6D). In summary, mutations in either BAH or chromo
domains of CMT3 abolish its methylation activity in vivo.
We also analyzed the effect of the chromo and BAHmutations
on the binding of CMT3 to nucleosomes. Silver staining of
proteins copurifying with CMT3 showed that, unlike the situation
in wild-type CMT3, proteins copurifying with the CMT3chr3 and
CMT3bah3 mutants lacked the low molecular weight bands cor-
responding to histone proteins (Figure 1B), which was further
confirmed byMS analysis on affinity-purified CMT3chr3 samples
(Table S2) and by ChIP experiments showing that mutations
of either BAH or chromodomain abolish CMT3 binding toCell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc. 175
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Figure 6. Both BAH and Chromo Domains Are Important for CMT3 Function In Vivo
(A) Southern blot of the 5S rDNA locus.
(B) Graphical representation of bisulfite sequencing analysis of Ta3 locus.
(C) Western blots showing the expression of the wild-type and mutant versions of the CMT3 protein. The bottom panel is the Coomassie blue staining and serves
as a loading control.
(D) In vitro activity assay. Error bars represent the standard deviation of three biological replicates.
(E) ChIP data showing the failure of CMT3chr3 and CMT3bah3 to bind to chromatin at Ta3 and SDC. Error bars represent the SD of three biological replicates.
(F) A workingmodel of dual-recognition mechanism of CMT3BAH and chromo domains simultaneously reading the H3K9me2 on a single nucleosome to position
the methyltransferase domain over the nucleosomal DNA.
See also Figures S6 and Table S2.
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chromatin (Figure 6E). These results indicate that both the
chromo and BAH domains are required for stable association
of CMT3 with nucleosomes.
While the CMT3chr3 mutation abolished the interaction of
CMT3 with nucleosomes, we found that CMT3chr3 retained
similar in vitro catalytic activity as that of wild-type CMT3 (Fig-
ure 6D). This suggests that H3K9me2 acts as a recruitment
factor for CMT3 in vivo.
DISCUSSION
Nucleosome occupancy is an important determinant of global
DNA methylation patterns in vivo (Chodavarapu et al., 2010).
The association of CMT3 with nucleosomes suggests that
CMT3 may methylate nucleosome-bound DNA, which may
explain our previous observations from whole genome shotgun
bisulfite sequencing that CHG methylation was enhanced on
nucleosomal DNA relative to linker DNA and that CHG sites
facing on the outside of nucleosomes were methylated at
a higher level than those facing on the inside (Chodavarapu
et al., 2010). This model also explains the 167 nt periodicity
pattern of CHG methylation previously observed in bulk analysis
of whole genome methylation data (Cokus et al., 2008).
The observation that CMT3 is predominately expressed in
cells undergoing active replication implies that methylation by
CMT3 takes place during DNA replication, when H3.1 is incorpo-
rated onto newly synthesized chromatin and modified by the
histone H3K9 methyltransferase, KYP. One plausible model is
that CMT3 is displaced from nucleosomes during replication.
Once replication is completed, it is recruited back to the newly
assembled nucleosomes that have been methylated by KYP
(or other SUVHs) on H3K9. Alternatively, CMT3may be recruited
to chromatin during DNA replication by premodified H3K9me2
marks from parental histones. In turn, CHG methylation would
recruit KYP to deposit methylation marks on newly synthesized
histones.
We attempted to test whether the H3K9-specific histone
methyltransferase KYP (SUVH4) or possibly SUVH5 and SUVH6
(two other H3K9 methyltransferases) would form a complex with
CMT3. However, the CMT3 IP-MS analysis did not detect any
KYP, SUVH5, or SUVH6 peptides. Reciprocal IP experiments
with protein extracts from Nicotiana benthamiana leaves coex-
pressing MYC-tagged CMT3 and FLAG-tagged KYP also failed
to detect interaction between CMT3 and KYP (data not shown).
These findings suggest either that KYP is not stably associated
with nucleosomes, or that KYP andCMT3 cannot simultaneously
remain bound to the same nucleosomes.
Our in vitro activity assays show that CMT3 has some activity
on unmethylated DNA. We speculate that this ‘‘de novo’’ activity
is in fact part of the ‘‘maintenance’’ loop of KYP and CMT3.
Unlike the mammalian maintenance DNA methyltransferase
DNMT1, which has much greater activity on hemimethylated
DNA than on unmethylated DNA (Bestor and Ingram, 1983),
CMT3 only has slightly higher activity on hemimethylated
substrates than unmethylated substrates. In addition, our data
suggested that CMT3 showed only a small tendency to fully
methylate CHG sites in vivo rather than leaving them hemimethy-
lated, which is in contrast to the strong tendency of DNMT1 tofully methylate CG sites in vivo. This suggests that CMT3 is not
as good as DNMT1 at restoring hemimethylated sites to fully
methylated sites and consequently, methylation at many sites
will be completely lost during multiple cycles of replication. The
‘‘de novo’’ activity of CMT3, however, could persistently target
methylation to regions marked with H3K9 methylation. CMT3’s
inefficiency at maintaining methylation is also reflected by the
fact that the overall global levels of CHG methylation (6.7%)
are much lower than those of CG methylation (24%) (Cokus
et al., 2008). In addition to the preference for hemimethylated
DNA as substrate, DNMT1 and MET1 work with the UHRF1/
VIM cofactor that specifically recognizes hemimethylated
DNA through its SRA domain (Bostick et al., 2007). However,
the SRA domain of KYP and SUVH5 bind equally well to hemime-
thylated and fully methylated DNAs (Johnson et al., 2007;
Rajakumara et al., 2011a). Therefore, CMT3’s ‘‘maintenance’’
activity is likely to be drivenmainly by the feedback loop between
KYP and CMT3, rather than by the inherent preference of CMT3
for hemimethylated DNA.
H3K27me1 is enriched in heterochromatin and was proposed
to be involved in CMT3 function based on in vitro data showing
that the chromodomain of CMT3 bound to histone H3 peptides
only when both H3K9 and H3K27 were methylated (Lindroth
et al., 2004). However, these doubly methylated peptides were
longer than the singly methylated control peptides, which might
be an alternative explanation for this result. More critically,
a recent study showed that depletion of H3K27me1 in vivo did
not reduce CHG methylation (Jacob et al., 2009). In addition,
our peptide array and structural analyses showed that H3K9me2
is necessary and sufficient to bind CMT3. Therefore, H3K27me is
unlikely to play a role in CMT3 targeting.
The BAH domain functions as a mediator of protein-protein
interactions. Yeast Sir3 BAH domain in complex with mononu-
cleosomes revealed that the BAH domain makes contacts
through unmodified H4K16 and H3K79 (Armache et al., 2011),
which are important for BAH-nucleosome binding (Onishi et al.,
2007). Recent studies of the mouse ORC1 BAH domain bound
to H4K20me2 peptide have established that methylated lysine
is recognized through positioning within an aromatic cage on
the surface of the BAH domain, and the methyl-lysine recogni-
tion mode is similar as the ZMET2 BAH domain recognizing
H3K9me2 peptide reported here (Figure S4E) (Kuo et al.,
2012). In the current study, we also observed that themethylated
lysine of H3K9me2 peptide was positioned within an aromatic
cage of the BAH domain of ZMET2. The aromatic cage residues
in the BAH domain of ZMET2, that are conserved among the
BAH domains of other plant chromomethylases, are also
observed within the BAH1 domain of human DNMT1. These
results imply that the BAH1 domain of DNMT1 may also be a
reader of methylated-lysine marks using aromatic cage capture.
By contrast, no aromatic cage was identified following alignment
of the BAH2 domain of DNMT1.
How is CHG methylation precisely controlled and faithfully
maintained? We propose a dual-recognition mechanism, in
which the CMT3 BAH and chromo domains simultaneously
read the H3K9me2 on the two tails emanating from a single
nucleosome to ensure a higher fidelity of CHG DNA methylation
(Figure 6F). In the crystal, we are restricted to one or the otherCell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc. 177
complex most likely due to packing interactions, but there
should be no such constraints for simultaneous recognition of
H3K9me2 marks by both BAH and chromo domains in solution.
Indeed, ITC binding studies yield a stoichiometry of 1.8 for
binding of H3(1–15)K9me2 peptide to ZMET2 (Figure S6A).
Modeling efforts indicate that it is possible that two H3K9m2
modified tails could extend from the single nucleosome and
bind to the chromo and BAH domains simultaneously. The
nucleosomal DNA between the two H3 tails could be clamped
by the TRD subdomain and the catalytic loop and subsequently
methylated (Figures S6B and S6C). The H3 tail has sufficient
length so as to likely allow the enzyme enough flexibility to cata-
lyze on a range of nucleosomal DNA. The two-domain binding
mode could potentially increase CMT3’s binding affinity and
specificity toward H3K9me2 marks and thus help to recruit
CMT3 to H3K9me2-containing nucleosomes. It is also conceiv-
able that the dual binding modules could help CMT3 walk
from nucleosomes to adjacent nucleosomes, characteristic of
a spreading mechanism. Interestingly, the mammalian de novo
DNA methyltransferase DNMT3A/3L complex also binds stably
to nucleosomes (Jeong et al., 2009), and DNMT3A and DNMT3L
each have an unmodified H3K4-recognizing ADD domain,
suggesting that the DNMT3A/3L complex may also have the
potential for dual recognition of two unmodified H3K4-contain-
ing tails of a nucleosome. By contrast, DNMT1 only contains
one BAH domain that has a potential methyl-lysine binding
cage and is not tightly associated with nucleosomes (Jeong
et al., 2009). Thus, a dual histone tail recognition mode may be
a common feature of DNA methyltransferase that are stably
bound to chromatin.
EXPERIMENTAL PROCEDURES
Immunoprecipitation and Mass Spectrometry
Epitope-tagged CMT3 transgenic plants were generated and used for IP-MS
analysis as described previously (Law et al., 2010) and detailed information
can be found in the Extended Experimental Procedures.
Western Blot
The FLAG and MYC epitope tags were detected using the anti-Flag M2mono-
clonal antibody (Sigma, A8592) and anti-Myc 9E10 monoclonal antibody
(Covance, MMS-150B), respectively. Primary antibodies used for histones
included: anti-histone H3 antibody (Abcam, ab10799), anti-histone H3K9me2
(Abcam, ab1220-100), and anti-histone H3K4me2 (Abcam, ab32356).
Immunofluorescence
EdU labeling of BLRP-9xMYC-CMT3 transgenic root cells was based on the
Click-iT kit (Invitrogen) and immunofluorescence analysis was described in
detail in the Extended Experimental Procedures.
Protein Purification and Histone Peptide Array
Recombinant CMT3 and ZMET2 protein expression and purification were
based on (Song et al., 2011) and described in detail in the Extended Experi-
mental Procedures. MODified histone peptide array slide (Active Motif,
13001) was blocked by incubation in TBS buffer (10 mM Tris-HCl [pH 7.5]
and 150 mM NaCl) containing 5% milk at room temperature (RT) for 1 hr and
washed three times with TTBS buffer (10 mM Tris-HCl [pH 7.5], 150 mM
NaCl, and 0.05% Tween-20). The array slide was then incubated with 30 mg
purified proteins in 3 ml binding buffer (50 mM HEPES [pH 7.5], 50 mM
NaCl, 5% glycerol, 0.4% BSA, and 2 mM DTT) overnight at 4C, washed three
times with TTBS buffer and incubated with anti-His antibody in TBS buffer for
1 hr at RT. The array was washed three times with TTBS and developed by178 Cell 151, 167–180, September 28, 2012 ª2012 Elsevier Inc.enhanced chemiluminescence. The images were analyzed according to the
instruction of array analysis software.
DNA Methyltransferase Assay
Baculovirus-mediated CMT3 expression and purification were performed as
previously described (Patnaik et al., 2004). DNA methyltransferase activity
assay was described in detail in the Extended Experimental Procedures.
Hairpin Bisulfite Sequencing
Genomic DNAwas digestedwith BglII restriction enzyme and ligatedwith oligo
(/5Phos/GATCTGCGATCGDDDDDDDGCATCGCA) by T4 DNA ligase (NEB).
JP3200 and JP1615 primers were used to amplify Ta3 hairpin bisulfite treated
DNA. Methylation on both strands of the DNA was assayed in 21 clones from
wild-type plants. Chi-square value was calculated by using standard chi-
square formula (the sum of squared observedminus expected over expected).
The expected number of dyads was calculated based on the observed cyto-
sine methylation percentage and four possible combinations of methylated
and unmethylated cytosines in a dyad. Calculated chi-square value, together
with degree of freedom of two, was used to obtain probability based on the
chi-square distribution table.
Chromatin Immunoprecipitation
ChIP was based on IP with the following modifications. Micrococcal nuclease
was included in crude extracts to shear chromatin before incubation with
beads. The eluted protein-DNA complexes were treated by proteinase K fol-
lowed by phenol:chlorophorm purification. The enriched DNA was ethanol
precipitated and subjected to library generation following Illumina’s manufac-
turer instructions (see Extended Experimental Procedures).
ChIP-Seq and RNA-Seq Data Analyses
Illumina base-called reads were mapped with Bowtie (Langmead et al.,
2009) allowing up to two mismatches. For ChIP-seq, identical reads were
collapsed into one read. Both gene and transposon expressions were mea-
sured by calculating reads per kilobase per million mapped reads (RPKM).
p values were calculated using Fisher’s exact test and Benjamini corrected
for multiple testing. Differentially expressed elements in wild-type and
mutants were defined by applying log2(mutant /wild-type) > 2 and p < 0.05
cutoffs.
Crystallization, Structure Determination, and Refinement
Crystals were grown using the hanging drop vapor diffusion method and the
diffraction data were collected at the NE-CAT beamline 24ID-E, Advanced
Photon Source (APS) at the Argonne National Laboratory, Chicago, and pro-
cessed with the program HKL2000 (Otwinowski and Minor, 1997). The struc-
ture of Se-substituted ZMET2 in the presence of SAH and the structures of
ZMET2 in complex with H3K9me2 peptides in the presence of SAH were
solved using SAD method and molecular replacement method, respectively,
as implemented in the program Phenix (Adams et al., 2010). The model
building was carried out using the program Coot (Emsley et al., 2010).
The statistics of the diffraction data and the refinement are summarized in
Table S5. Additional details are provided in the Extended Experimental
Procedures.
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